深交所:對長生生物科技股份有限公司及相關當事人給予公開譴責處分
中證網(wang)訊(記(ji)者 黃靈靈)深交所5月20日公(gong)(gong)告(gao)稱,經(jing)(jing)查明,長(chang)生(sheng)生(sheng)物科(ke)技(ji)股(gu)(gu)份有限(xian)公(gong)(gong)司及相關當事人存(cun)在(zai)重大(da)事項(xiang)未(wei)披(pi)露(lu)、信息披(pi)露(lu)存(cun)在(zai)虛(xu)假記(ji)載、未(wei)在(zai)規定期限(xian)內披(pi)露(lu)定期報告(gao)等三項(xiang)違規行為(wei),決定對(dui)長(chang)生(sheng)生(sheng)物科(ke)技(ji)股(gu)(gu)份有限(xian)公(gong)(gong)司給予公(gong)(gong)開譴責的(de)處分(fen);對(dui)長(chang)生(sheng)生(sheng)物科(ke)技(ji)股(gu)(gu)份有限(xian)公(gong)(gong)司董(dong)(dong)事長(chang)、總(zong)經(jing)(jing)理(li)、財務(wu)總(zong)監高俊芳,副董(dong)(dong)事長(chang)、副總(zong)經(jing)(jing)理(li)張(zhang)洺(ming)豪,董(dong)(dong)事、副總(zong)經(jing)(jing)理(li)張(zhang)晶,董(dong)(dong)事、董(dong)(dong)事會秘書趙春志,副總(zong)經(jing)(jing)理(li)張(zhang)友(you)奎、蔣強(qiang)華(hua)、劉景曄給予公(gong)(gong)開譴責的(de)處分(fen)。